Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-07T21:23:49.277Z Has data issue: false hasContentIssue false

Chapter 47 - Human Immunodeficiency Virus Infection and Pregnancy

Published online by Cambridge University Press:  29 September 2017

Martin Olsen
Affiliation:
East Tennessee State University
Get access
Type
Chapter
Information
Obstetric Care , pp. 442 - 453
Publisher: Cambridge University Press
Print publication year: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Connor, EM, Sperling, RS, Gelber, R, et. al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331(18):11731180.CrossRefGoogle Scholar
Townsend, CL, Byrne, L, Cortina-Borja, M, et al. Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011. AIDS. 2014;28(7):10491057.CrossRefGoogle ScholarPubMed
Forbes, JC, Alimenti, AM, Singer, J, et al. A national review of vertical HIV transmission. AIDS. 2012;26(6):757763.Google Scholar
Ioannidis, JP, Contopoulos-Ioannidis, DG. Maternal viral load and the risk of perinatal transmission of HIV-1. N Engl J Med. 1999 Nov 25;341(22):16981700.Google Scholar
Panel on treatment of HIV-infected pregnant women and prevention of perinatal transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf. Accessed March 19, 2016.Google Scholar
Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data – United States and 6 dependent areas, 2012. HIV Surveillance Supplemental Report 2014;19(3). www.cdc.gov/hiv/library/repors/surveillance/. Published November 2014. Accessed February 27, 2016.Google Scholar
Skarbinski, J, Rosenberg, E, Paz-Bailey, G, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med. 2015;175:588596.Google Scholar
Centers for Disease Control and Prevention. HIV Among Women, Infants, and Children. Available at www.cdc.gov/hiv/group/gender/pregnantwomen/. Page updated June 15, 2015. Accessed March 19, 2016.Google Scholar
Centers for Disease Control and Prevention. Reduction in perinatal transmission of HIV infection – United States, 1985–2005. MMWR 2006;55:592597.Google Scholar
Branson, BM, Handsfield, HH, Lampe, MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Sept 22, 2006;55(RR14);117.Google Scholar
ACOG Committee Opinion No 635. Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. American College of Obtetricians and Gynecologists. Obstet Gynecol. 2015 Jun;125(6):15441547.Google Scholar
Centers for Disease Control and Prevention and Association of Public Health Laboratories. Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations. Available at http://stacks.cdc.gov/view/cdc/23447. Published June 27, 2014. Accessed February 20, 2016.Google Scholar
Vogler, MA, Patterson, K, Kamemoto, L, et al. Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188. J Acquire Immune Defic Syndr. 2010;55(4):437–82.Google ScholarPubMed
Stringer, EM, Kaseba, C, Levy, J, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol 2007;197:144.e1144.e8.Google Scholar
Robinson, JA, Jamshidi, R, Burke, AE. Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy. Infect Dis Obstet Gynecol. 2012;2012:890160. doi:10.1155/2012/890160. Available at www.hindawi.com/journals/idog/2012/890160/Google Scholar
Landolt, NK, Phanuphak, N, Ubolyam, S, et al. Significant decrease of ethinylestradiol with nevirapine, and of etonogestrel with efavirenz in HIV-positive women. J Acquir Immune Defic Syndr. 2014;66(2):e50e52. Available at www.ncbi.nlm.nih.gov/pubmed/24608892.Google Scholar
Perry, SH, Swamy, P, Preidis, GA, Mwanyumba, A, Motsa, N, Sarero, HN. Implementing the Jadelle implant for women living with HIV in a resource-limited setting in sub-Saharan Africa: concerns for drug interactions leading to unintended pregnancies. AIDS. 2014. Available at www.ncbi.nlm.nih.gov/pubmed/24401645.Google Scholar
Morrison, CS, Sekadde-Kigondu, C, Sinei, SK, Weiner, DH, Kwok, C, Kokonya, D. Is the intrauterine device appropriate contraception for HIV-1-infected women?. BJOG. 2001;108: 784790.Google Scholar
ACOG Committee Opinion No 313. The importance of preconception care in the continuum of women’s healthcare. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2005 Sep;106(3):665666.Google Scholar
Lampe, MA, Smith, DK, Anderson, GJE, et al. Achieving safe conception in HIV-discordant couples: the potential role of oral preexposure prophylaxis (PrEP) in the United States. Am J Obstet Gynecol 2011;204:488.e1–8.CrossRefGoogle ScholarPubMed
Matthews, L, Smit, J, Cu-Uvin, S, Cohan, D. Antiretrovirals and safer conception for HIV-serodiscordant couples. Curr Opin HIV AIDS. 2012, 7:569578.Google Scholar
Ethics Committee of the American Society for Reproductive M. Human immunodeficiency virus and infertility treatment. Fertil Steril. 2010;94(1):1115.Google Scholar
Semprini, AE, Macaluso, M, Hollander, L, et al. Safe conception for HIV-discordant couples: Insemination with processed semen from the HIV-infected partner. Am J Obstet Gynecol. 2013 May;208(5):402.e1–9.CrossRefGoogle ScholarPubMed
Vernazza, PL, Graf, I, Sonnenberg-Schwan, U, et al. Preexposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child. AIDS. 2011;25(16):20052008.Google Scholar
CDC. Preexposure prophylaxis for the prevention of HIV infection in the United States-2014. www.cdc.gov/hiv/pdf/prepguidelines2014.pdf. Accessed March 19, 2016.Google Scholar
Garcia, PM, Kalish, LA, Pitt, J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med. 1999;341(6):394402.CrossRefGoogle ScholarPubMed
Cooper, ER, Charurat, M, Mofenson, L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29:484494.Google Scholar
Jourdain, G, Mary, JY, Coeur, SL, Ngo-Giang-Huong, N, Yuthavisuthi, P, Limtrakul, A, et al. Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand. J Infect Dis. 2007;196(11):16291636.Google Scholar
Whitmore, SK, Taylor, AW, Espinoza, L, Shouse, RL, Lampe, MA, Nesheim, S. Correlates of mother-to-child transmission of HIV in the United States and Puerto Rico. Pediatrics. 2012;129;e74e81.Google Scholar
Drake, AL, Wagner, A, Richardson, B, John-Stewart, G. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: A systematic review and meta-analysis. PLoS Med Feb 2014;11(2):e1001608. doi:10.1371/journal.pmed.1001608.Google Scholar
Burns, DN, Landesman, S, Muenz, LR, et al. Cigarette smoking, premature rupture of membranes and vertical transmission of HIV-1 among women with low CD4 levels. J Acquir Immune Defic Syndr Hum Retrovirol. 1994;7(7):718726.Google Scholar
Turner, BJ, Hauck, WW, Fanning, TR, Markson, LE. Cigarette smoking and maternal–child HIV transmission. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14(4):327337.Google Scholar
Rodriguez, EM, Mofenson, LM, Chang, BH, et al. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS. 1996;10(3):273282.Google Scholar
Bulterys, M, Landesman, S, Burns, DN, et al. Sexual behavior and injection drug use during pregnancy and vertical transmission of HIV-1. J Acquir Immune Defic Syndr Human Retrovirol. 1997;15(1):7682.Google Scholar
Matheson, PB, Thomas, PA, Abrams, EJ, et al. New York City Perinatal HIV Transmission Collaborative Study Group. Heterosexual behavior during pregnancy and perinatal transmission of HIV-1. AIDS. 1996;10(11):12491256.Google Scholar
Read, PJ, Mandalia, S, Khan, P, et al. When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery? AIDS. 2012;26(9):10951103.Google Scholar
Tubiana, R, Le Chenadec, J, Rouzioux, C, et al. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: A case–control study nested in the French perinatal cohort (EPF-ANRS CO1). Clin Infect Dis. 2010;50(4):585596.Google Scholar
Ford, N, Mofenson, L, Shubber, Z, et al. Safety of efavirenz in the first trimester of pregnancy: An updated systematic review and meta-analysis. AIDS. 2014;28 Suppl 2:S123S131.Google Scholar
Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed March 19, 2016.Google Scholar
Aziz, N, Sokoloff, A, Kornak, J, et al. Time to viral load suppression in antiretroviral-naive and -experienced HIV infected pregnant women on highly active antiretroviral therapy: Implications for pregnant women presenting late in gestation. BJOG 2013;120(12):15341547.Google Scholar
Wong, VV. Is peripartum zidovudine absolutely necessary for patients with a viral load less than 1,000 copies/ml? J Obstet Gynaecol. 2011;31(8):740742.Google Scholar
Briand, N, Warszawski, J, Mandelbrot, L, et al. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era? Clin Infect Dis. 2013;57(6):903914.Google Scholar
Cotter, AM, Brookfield, KF, Duthely, LM, Gonzalez Quintero, VH, Potter, JE, O’Sullivan, MJ. Duration of membrane rupture and risk of perinatal transmission of HIV-1 in the era of combination antiretroviral therapy. Am J Obstet Gynecol. 2012;207(6):482 e481–485.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×